Latest Lausanne Stories
LAUSANNE, Switzerland, April 30 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions, particularly in the field of oncology, announced that on April 7, 2009 the last patient was randomised to take part in a phase IIb clinical study with Debio 025, a selective cyclophilin (Cyp) inhibitor with a potent anti-hepatitis C (HCV) effect.
World Malaria Day Events Held in Nairobi, London, Washington LAUSANNE, Switzerland, April 23 /PRNewswire/ -- To honor the theme for World Malaria Day on 4/25, 'Counting Malaria Out,' Vestergaard Frandsen is stepping up production of its best selling bed net, called PermaNet(R), and introducing a new version that is effective against insecticide resistant mosquitoes.
Researchers at the Swiss Institute of Bioinformatics and the Swiss National Center of Competence in Research in Molecular Oncology in Lausanne have developed a new test to predict how breast cancer patients respond to chemotherapy, which could help change how treatment is delivered in the future.
LAUSANNE, Switzerland, December 10 /PRNewswire/ -- Diagnoplex, a developer of molecular cancer diagnostics today announced the closing of a Series A financing raising CHF10 million ($8.3 million).
LAUSANNE, Switzerland, November 4 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, announced today that Debiovision Inc., its Canadian affiliate, filed its Complete Response to the approvable letter received from the United States (U.S.) Food and Drug Administration (FDA) for Sanvar(R), or Debio 8609 (vapreotide acetate).
SAN DIEGO and LAUSANNE, Switzerland, Sept. 5 /PRNewswire/ -- Westcore Properties announced today that its European affiliate Airport Development Partners SA (ADP), has appointed Dr. Hans-Peter Kohlhammer and Jan Danielsson to its Advisory Board.
Debiopharm Group, which focuses on serious medical conditions and particularly oncology, has signed a research project agreement with Ecole Polytechnique Federale de Lausanne, aimed at the identification of novel small molecules and peptides that interfere with pathways controlling cell fate specification.
LAUSANNE, Switzerland, September 2 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist focusing on serious medical conditions and particularly oncology, today announced the signature of a research project with the Ecole Polytechnique Federale de Lausanne (EPFL), aimed at the identification of novel small molecules and peptides that interfere with pathways controlling cell fate specification.
An international Internet scam has offered thousands of fake tickets to sports fans for the Beijing Games, according to Olympic officials on Monday.
By Jere Longman "One World, One Dream," is the official motto of the Beijing Olympics, opening Friday, but the world has become considerably more complicated since the International Olympic Committee awarded the 2008 Summer Games to China seven years ago.
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).